1 active not recruiting, 1 terminated, 1 withdrawn. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow Small Bowel Cancer: new trials by email Literature Review of Small Bowel Cancer trials Research Report on Small Bowel Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies KRAS TCR-Transduced PBL, Aldesleukin, Fludarabine - Gastrointestinal Carcinoma, Pancreatic Cancer | Phase 2 | Withdrawn | National Cancer Institute (NCI) | 2025-09-09 | 2025-09-11 | |
| Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas IMT-009, Fruquintinib - Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma | Phase 1 / Phase 2 | Active not recruiting | Immunitas Therapeutics | 67 | 2022-11-28 | 2025-10-16 |
| Effects of S-1 and Capecitabine on Coronary Artery Blood Flow S-1, Capecitabine, Oxaliplatin - Esophagus Cancer, Stomach Cancer | Phase 2 | Terminated | Heikki Joensuu | 20 | 2015-01-01 | 2018-08-28 |
Colorectal Neoplasms (2) · Esophageal Neoplasms (2) · Burkitt Lymphoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Cholangiocarcinoma (1) · Colonic Neoplasms (1) · Duodenal Neoplasms (1) · Gastrointestinal Neoplasms (1) · Hodgkin Disease (1) · Liver Neoplasms (1) · Lymphoma (1) · Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1) · Neoplasms (1) · Pancreatic Neoplasms (1)
Colonic Diseases (3) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Gastrointestinal Diseases (3) · Intestinal Diseases (3) · Intestinal Neoplasms (3) · Neoplasms by Site (3) · Rectal Diseases (3) · Carcinoma (2) · Esophageal Diseases (2) · Gastrointestinal Neoplasms (2) · Head and Neck Neoplasms (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2)
Capecitabine (1) · Cyclophosphamide (1) · HMPL-013 (1) · Oxaliplatin (1) · S 1 (combination) (1) · aldesleukin (1) · fludarabine (1) · tegafur-gimeracil-oteracil (1)
Heikki Joensuu (1) · Immunitas Therapeutics (1) · National Cancer Institute (NCI) (1)
United States (2) · Finland (1)
Heikki Joensuu, MD (1) · Nicholas D Klemen, M.D. (1)